Abbott Laboratories (ABT)

Health Care·equity
$99.60
+1.13% today
Extended hours $99.78
Prices delayed about 15 minutes · cached page, can be an hour old or more
Market Census Score
48/ 100
Score level
Average
6 of 6 checks had data

Score for how it compares with the broader market is on the low side; price trend score is on the high side, business numbers score is above the middle.

ABT scores higher than 65% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Abbott Laboratories (ABT) scores 48 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated · scores usually change about once a day

TrendStrengthFinancialsInsidersMarketMomentum48/ 100

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume
0.78× 30-day average
52-week range
81.97 – 135.12
Market cap
$177.55B
Earnings date
21 Oct 2026
Dividend yield
1.98%
Volume
6,961,975
Avg. volume (30d)
8,883,094
Open
98.41
Previous close
98.49
Day's range (regular session)
98.20 – 100.36

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta
0.55
P/E (TTM)
31.03
EPS (TTM)
3.11

Score breakdown · six named factors

Price trend
69
Strength vs the market
27
Company finances
63
Insider trades
33
Market mood
50
Recent momentum
42

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for ABT

  • 10 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for ABT. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about ABT right now

Abbott Laboratories (ABT) currently scores 48/100 on the Market Census six-factor composite, at the Average score level. ABT is +1.13% on the day and +2.23% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in ABT's data roughly balance out right now. ABT's strongest factor is price trend at 69/100 — a strong read on which way the price has been going. The weakest factor is strength vs the market at 27/100 — below average next to the wider market.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See ABT in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Recent ABT news

Latest headlines that name Abbott Laboratories, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).

We hide 5 more that told readers to buy or sell, or gave a price target.

Saved snapshot; the news and prices on this page can be an hour old or more.

Similar setups in Health Care right now

Six health care tickers whose composite scores are closest to ABT’s 48, all within 1 point.

Sorted by closeness to ABT’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →

Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.